Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

T lymphocytes facilitate brain metastasis of breast cancer by inducing Guanylate-Binding Protein 1 expression.

Mustafa DAM, Pedrosa RMSM, Smid M, van der Weiden M, de Weerd V, Nigg AL, Berrevoets C, Zeneyedpour L, Priego N, Valiente M, Luider TM, Debets R, Martens JWM, Foekens JA, Sieuwerts AM, Kros JM.

Acta Neuropathol. 2018 Apr;135(4):581-599. doi: 10.1007/s00401-018-1806-2. Epub 2018 Jan 19.

2.

Cancer-associated fibroblast promote transmigration through endothelial brain cells in three-dimensional in vitro models.

Choi YP, Lee JH, Gao MQ, Kim BG, Kang S, Kim SH, Cho NH.

Int J Cancer. 2014 Nov 1;135(9):2024-33. doi: 10.1002/ijc.28848. Epub 2014 Mar 28.

3.

EBAG9 inducing hyporesponsiveness of T cells promotes tumor growth and metastasis in 4T1 murine mammary carcinoma.

Hong X, Liu Y, Hu G, Zhao D, Shen J, Shen F, Cao X, Wang Q.

Cancer Sci. 2009 May;100(5):961-9.

4.

miR-509 suppresses brain metastasis of breast cancer cells by modulating RhoC and TNF-α.

Xing F, Sharma S, Liu Y, Mo YY, Wu K, Zhang YY, Pochampally R, Martinez LA, Lo HW, Watabe K.

Oncogene. 2015 Sep 10;34(37):4890-900. doi: 10.1038/onc.2014.412. Epub 2015 Feb 9.

5.

Roles of the cyclooxygenase 2 matrix metalloproteinase 1 pathway in brain metastasis of breast cancer.

Wu K, Fukuda K, Xing F, Zhang Y, Sharma S, Liu Y, Chan MD, Zhou X, Qasem SA, Pochampally R, Mo YY, Watabe K.

J Biol Chem. 2015 Apr 10;290(15):9842-54. doi: 10.1074/jbc.M114.602185. Epub 2015 Feb 17.

6.

αB-crystallin: a novel regulator of breast cancer metastasis to the brain.

Malin D, Strekalova E, Petrovic V, Deal AM, Al Ahmad A, Adamo B, Miller CR, Ugolkov A, Livasy C, Fritchie K, Hamilton E, Blackwell K, Geradts J, Ewend M, Carey L, Shusta EV, Anders CK, Cryns VL.

Clin Cancer Res. 2014 Jan 1;20(1):56-67. doi: 10.1158/1078-0432.CCR-13-1255. Epub 2013 Oct 16.

7.
8.

Disruption of the blood brain barrier by brain metastases of triple-negative and basal-type breast cancer but not HER2/neu-positive breast cancer.

Yonemori K, Tsuta K, Ono M, Shimizu C, Hirakawa A, Hasegawa T, Hatanaka Y, Narita Y, Shibui S, Fujiwara Y.

Cancer. 2010 Jan 15;116(2):302-8. doi: 10.1002/cncr.24735.

9.

Guanylate binding protein 1 is a novel effector of EGFR-driven invasion in glioblastoma.

Li M, Mukasa A, Inda MM, Zhang J, Chin L, Cavenee W, Furnari F.

J Exp Med. 2011 Dec 19;208(13):2657-73. doi: 10.1084/jem.20111102. Epub 2011 Dec 12.

10.

Selective permeabilization of the blood-brain barrier at sites of metastasis.

Connell JJ, Chatain G, Cornelissen B, Vallis KA, Hamilton A, Seymour L, Anthony DC, Sibson NR.

J Natl Cancer Inst. 2013 Nov 6;105(21):1634-43. doi: 10.1093/jnci/djt276. Epub 2013 Oct 9.

11.

Role of the blood-brain barrier in the formation of brain metastases.

Wilhelm I, Molnár J, Fazakas C, Haskó J, Krizbai IA.

Int J Mol Sci. 2013 Jan 11;14(1):1383-411. doi: 10.3390/ijms14011383. Review.

12.

Guanylate-binding protein-1 is a potential new therapeutic target for triple-negative breast cancer.

Quintero M, Adamoski D, Reis LMD, Ascenção CFR, Oliveira KRS, Gonçalves KA, Dias MM, Carazzolle MF, Dias SMG.

BMC Cancer. 2017 Nov 7;17(1):727. doi: 10.1186/s12885-017-3726-2.

13.

Angiotensin II facilitates breast cancer cell migration and metastasis.

Rodrigues-Ferreira S, Abdelkarim M, Dillenburg-Pilla P, Luissint AC, di-Tommaso A, Deshayes F, Pontes CL, Molina A, Cagnard N, Letourneur F, Morel M, Reis RI, Casarini DE, Terris B, Couraud PO, Costa-Neto CM, Di Benedetto M, Nahmias C.

PLoS One. 2012;7(4):e35667. doi: 10.1371/journal.pone.0035667. Epub 2012 Apr 20.

14.

NOTCH3 expression is linked to breast cancer seeding and distant metastasis.

Leontovich AA, Jalalirad M, Salisbury JL, Mills L, Haddox C, Schroeder M, Tuma A, Guicciardi ME, Zammataro L, Gambino MW, Amato A, Di Leonardo A, McCubrey J, Lange CA, Liu M, Haddad T, Goetz M, Boughey J, Sarkaria J, Wang L, Ingle JN, Galanis E, D'Assoro AB.

Breast Cancer Res. 2018 Sep 4;20(1):105. doi: 10.1186/s13058-018-1020-0.

15.

Ex vivo Evans blue assessment of the blood brain barrier in three breast cancer brain metastasis models.

Do J, Foster D, Renier C, Vogel H, Rosenblum S, Doyle TC, Tse V, Wapnir I.

Breast Cancer Res Treat. 2014 Feb;144(1):93-101. doi: 10.1007/s10549-014-2854-5. Epub 2014 Feb 8.

16.

Astrocyte-induced Reelin expression drives proliferation of Her2+ breast cancer metastases.

Jandial R, Choy C, Levy DM, Chen MY, Ansari KI.

Clin Exp Metastasis. 2017 Feb;34(2):185-196. doi: 10.1007/s10585-017-9839-9. Epub 2017 Feb 17.

PMID:
28210910
17.

Role of KCNMA1 gene in breast cancer invasion and metastasis to brain.

Khaitan D, Sankpal UT, Weksler B, Meister EA, Romero IA, Couraud PO, Ningaraj NS.

BMC Cancer. 2009 Jul 29;9:258. doi: 10.1186/1471-2407-9-258.

18.

Inhibition of Polo-like kinase 1 prevents the growth of metastatic breast cancer cells in the brain.

Qian Y, Hua E, Bisht K, Woditschka S, Skordos KW, Liewehr DJ, Steinberg SM, Brogi E, Akram MM, Killian JK, Edelman DC, Pineda M, Scurci S, Degenhardt YY, Laquerre S, Lampkin TA, Meltzer PS, Camphausen K, Steeg PS, Palmieri D.

Clin Exp Metastasis. 2011 Dec;28(8):899-908. doi: 10.1007/s10585-011-9421-9. Epub 2011 Sep 21.

PMID:
21953073
19.

Discordances in ER, PR, and HER2 between primary breast cancer and brain metastasis.

Jung J, Lee SH, Park M, Youn JH, Shin SH, Gwak HS, Yoo H.

J Neurooncol. 2018 Apr;137(2):295-302. doi: 10.1007/s11060-017-2717-0. Epub 2017 Dec 19.

20.

ADAM8 expression in breast cancer derived brain metastases: Functional implications on MMP-9 expression and transendothelial migration in breast cancer cells.

Conrad C, Götte M, Schlomann U, Roessler M, Pagenstecher A, Anderson P, Preston J, Pruessmeyer J, Ludwig A, Li R, Kamm RD, Ritz R, Carl B, Nimsky C, Bartsch JW.

Int J Cancer. 2018 Feb 15;142(4):779-791. doi: 10.1002/ijc.31090. Epub 2017 Oct 31.

Supplemental Content

Support Center